| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4eef998c9e0425076246d27faa4f74c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30d0574000d5eaae24dbe7cb2d4ccc3f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06G7-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-30 |
| filingDate |
2004-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f8fad7fde8c956f7e212a5c2ae630e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87028541f3653f00880704c8d6a048df |
| publicationDate |
2006-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1718321-A2 |
| titleOfInvention |
Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein |
| abstract |
Disclosed are compositions and methods that relate generally to human immunodeficiency virus (HIV), and more particularly to the agents and their identification and use of anti-HIV agents which interfere with binding of a target amino acid sequence within glycoprotein 160 of HIV-1 to its ligand. Further disclosed is a composition comprising the molecule and a suitable carrier, and a method of decreasing interaction of human immunodeficiency virus with a host cell, the method comprising exposing one or both of the virus and the host cell to the molecule. |
| priorityDate |
2003-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |